- Benchmark ASINB0F3CBJXQM
- MarketplaceUS
- Category ID573758011
- Analyzed Products
- Keywordpower tool organizer
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥33.04estimated
- Data Date2026-07-23
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入，属于高风险且明显偏向价格竞争的赛道。 目前没有任何可靠证据显示它对小卖家友好；对大品牌来说也不是好机会，最多只能靠更重投入和更强渠道硬推进，但回报不确定。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论很直接：这个市场不适合进入，尤其不是预算友好的市场。 用户预算500,000 CNY约等于7万多美元，只够覆盖少数单品的前期进货、头程、FBA和基础投放，但这类市场已经被“通用款+低差异化”占满，连新品牌的新发产品盈利率都是0%，而且我们看到Mensarix这个新品牌两款新发产品全部亏损，说明现在不是靠正常预算就能跑通的环境。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):0.00%Alternatives- 改用“现有门锁把手翻新套件”或仅更换外观饰面件：如果用户主要是为了换黑色外观，这通常比整套前门把手更便宜，也更容易安装。
- 选择“标准机械门锁套装（带钥匙锁舌）”而不是高端一体式前门把手：在不追求造型升级时，普通门锁更常见、替换件更多、价格通常更低。
- 直接保留原有把手，只单独加装智能锁/按键锁：对于想提升入户便利性的人，这比整套门把手更容易实施，而且常可复用现有把手。
- 改用“门把手修复/更换五金件”而非整套更换：如果问题是松动、磨损或表面老化，单买锁舌、螺丝、面板等配件成本更低。
- 选择通用型室内/轻商用门把手或门锁：如果不是高频暴露在风雨中的外门场景，通用款往往更便宜，安装门槛也更低。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不适合进入。当前样本里只有 Mensarix 这一家新品牌，没有任何老品牌参与，谈不上大规模扩张；但这条线已经表现出“新品牌试水后直接踩坑”的特征：Mensarix 两个新品都亏，B0F3CBJXQM 虽然毛利率有 32.1%、月销约 50 件、月营收 2753.50 美元，但仍被判定为不盈利，且早期投入高达 6578.66 美元；另一个 B0H29NB5ZH 更是没有有效销量和收入。结论很直接：小卖家不该进，大品牌也没有看到足够强的成功样板去证明值得重投入。
证据上，这个市场的门槛不是“有利润率就行”，而是“利润率 + 销量”同时成立；Mensarix 的案例说明即便做到 32.1% 的账面利润，也因为销量和经营稳定性不足而失败。更关键的是，当前可见样本中100% 新品牌、0% 盈利品牌，没有任何“<300 评论的真实小卖家成功案例”可以当作复制对象；相反，B0F3CBJXQM 只有 110 条评论、却已经投入 6578.66 美元，说明这个类目要跑起来，资金消耗很重，且并没有形成健康回报。按你的规则，这种“新品牌全军覆没”的状态就是高风险信号，不是可进入信号。
New products with Highest revenueMost investment in new productsLeast investment in new productsMensarix
Recent Monthly Revenue (USD):-(-)B0H29NB5ZHBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$2,753.50(50pcs/month)B0F3CBJXQM (4.3/5 (110 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0F3CBJXQM (4.3/5 (110 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0H29NB5ZHBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing结论很直接：这个市场不适合进入，属于高风险、接近失真竞争的状态，小品牌不该进，大品牌也不该把它当成值得重投的赛道。 目前可见的新品牌只有 Mensarix，且 2 个新发布产品全部亏损，成功率 0%，这已经足够说明新进入者没有跑通模型；更糟的是，产品本身几乎没有差异化，属于标准通用款，说明不是靠创新赚钱，而是靠更重的投放和更强的品牌力硬推。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0F3CBJXQMMensarix2025-08-18No$55.0750pcs$2753.532.07%$883.05B0H29NB5ZHMensarix2026-05-19No$--pcs$--%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0F3CBJXQMMensarix2025-08-18No$55.0750pcs$2753.532.07%$883.05B0H29NB5ZHMensarix2026-05-19No$--pcs$--%$-#New Product Success Rates
Listing结论很明确：这个市场不值得进入，属于高风险、低成功率的价格竞争型市场。 目前只看到 1 个新品牌 Mensarix，2 个新品全部不盈利，市场新发布产品盈利率是 0.00%，连一个可验证的成功新品牌案例都没有；对你这种单品入场来说，这不是可复制的机会，而是先发进去先亏的局面。
证据很直接：Mensarix 作为新入场品牌，2 个新产品全失败，品牌盈利率 0.00%，其中 B0F3CBJXQM 虽然做到 32.1% 毛利、月销 50 件、月营收 2,753.50 美元，但最终仍被标记为非盈利，且早期投入高达 6,578.66 美元，广告就占 1,479.54 美元；另一个 ASIN B0H29NB5ZH 连销量和价格都无法稳定确认。 产品形态也很普通，都是标准前门把手/锁体通用款，差异化弱，说明这个类目更靠堆预算和渠道推进，不靠产品创新就很难跑出来。用户预算 500,000 CNY 虽然足够覆盖单个 ASIN 的前期成本，但在这里并不能换来确定性回报，因为当前样本里没有任何真正成功的新人小卖家案例，反而是接近“只见投入，不见盈利”的状态。
大品牌进入：可以做到，但不是好机会；小卖家进入：不建议，几乎没有合法低成本成功路径。 现在看不到成熟大品牌的稳定盈利样板，也看不到真实小卖家成功案例（<300 reviews/年）；唯一可见的 B0F3CBJXQM 只有 110 reviews，虽然没达到“疑似刷评”的 200+ 年阈值，但它仍然没转正，说明这个市场不是靠少量测试资金就能赢的。短结论：不要进入。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Mensarix#Success Rate by Entry Time
Listing这个市场不值得进入，已经明显偏向失败和价格战。 近期只有 1 个新品牌 Mensarix 入场，2 个新上架都失败，新增成功率是 0%，而且没有任何旧品牌成功样本可支撑“成熟但可做”的判断。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 1 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 1 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 1 2026/6 0 0 0 0 0 0 0 0 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases